Roivant Sciences (ROIV) Property, Plant & Equipment (Net) (2021 - 2026)
Powered by 
Analysis
Roivant Sciences (ROIV) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.68 Bn | 197.69 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 180.84 Bn | 177.66 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 61.49 Bn | 56.31 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 55.01 Bn | 49.87 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 34.08 Bn | 30.77 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.35 Bn | 30.06 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn | 11.32 Mn |
| 10 | Insmed | 27.84 Bn | 26.68 Bn | 358.27 Mn | 107.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.32 Mn |
| Mar 31, 2026 | 11.99 Mn |
| Dec 31, 2025 | 13.45 Mn |
| Sep 30, 2025 | 25.67 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Mar 31, 2025 | 12.06 Mn |
| Dec 31, 2024 | 13.56 Mn |
| Sep 30, 2024 | 13.67 Mn |
| Jun 30, 2024 | 17.84 Mn |
| Mar 31, 2024 | 15.32 Mn |
| Dec 31, 2023 | 21.86 Mn |
| Sep 30, 2023 | 24.48 Mn |
| Jun 30, 2023 | 36.27 Mn |
| Mar 31, 2023 | 39.09 Mn |
| Dec 31, 2022 | 37.30 Mn |
| Sep 30, 2022 | 39.17 Mn |
| Jun 30, 2022 | 31.69 Mn |
| Mar 31, 2022 | 25.91 Mn |
| Dec 31, 2021 | 21.61 Mn |
| Sep 30, 2021 | 16.90 Mn |